Organ Transplant Rejection: Signs, Types, and Treatment

Organ transplant rejection happens when the immune system recognizes a transplanted organ as foreign and tries to attack it. With careful monitoring, medication adherence, and early medical care, many rejection episodes can be treated effectively.

Overview

Organ transplant rejection is the immune system’s response to a transplanted organ that it identifies as unfamiliar. The immune system normally protects the body from infections and abnormal cells. After a transplant, however, it may also react against the donor organ because the donor’s tissue markers are not identical to the recipient’s.

Rejection can happen after any solid organ transplant, such as kidney, liver, heart, lung, pancreas, or intestine transplant. It does not mean that the patient has done something wrong, and it does not always mean the organ will fail. Many rejection episodes, especially acute rejection, can be controlled when recognized and treated early.

To reduce the risk, patients take immunosuppressive medicines, also called anti-rejection medicines. These medicines lower immune activity enough to protect the organ while still allowing the body to defend itself. Lifelong follow-up with a transplant team is important because rejection can be silent at first and may only be detected through scheduled tests.

Types of Organ Transplant Rejection

Transplant rejection is usually described by when it occurs and how the immune system attacks the organ. Hyperacute rejection is rare today because careful donor-recipient matching and crossmatch testing are performed before surgery. When it occurs, it happens very soon after transplant and is caused by pre-existing antibodies that react strongly with the donor organ.

Acute rejection is more common and can develop within weeks, months, or sometimes years after transplant. It may involve immune cells, antibodies, or both. Acute rejection can often be treated with adjustments in immunosuppressive therapy, especially when detected before severe organ injury develops.

Chronic rejection develops more slowly over months or years. It can cause progressive scarring, narrowing of blood vessels, and gradual loss of organ function. Chronic rejection is more difficult to reverse, so long-term prevention, monitoring, and management of risk factors are central to protecting the transplant.

Doctors may also use terms such as cellular rejection, antibody-mediated rejection, or mixed rejection. These terms describe what is seen in blood tests, antibody studies, imaging, or biopsy samples. Understanding the type of rejection helps the transplant team choose the most appropriate treatment plan.

Signs and Symptoms

Symptoms of transplant rejection vary depending on the organ and may be mild, vague, or absent. Some patients feel well even while laboratory results show early changes. For this reason, routine follow-up appointments are not optional; they are one of the safest ways to detect rejection before it causes noticeable problems.

Possible general warning signs include fever, flu-like feelings, fatigue, swelling, weight gain from fluid retention, pain or tenderness near the transplant area, or a general sense that something is not right. In kidney transplant patients, warning signs may include reduced urine output, swelling in the legs or face, rising blood pressure, or abnormal kidney blood tests.

For liver transplant patients, possible signs include yellowing of the skin or eyes, dark urine, pale stools, itching, abdominal swelling, or abnormal liver enzyme tests. Heart transplant rejection may cause shortness of breath, reduced exercise tolerance, irregular heartbeat, swelling, or fatigue. Lung transplant rejection may cause cough, breathlessness, lower oxygen levels, or a drop in lung function tests.

Because these symptoms can also be caused by infection, medication side effects, dehydration, or other conditions, patients should not try to diagnose rejection on their own. The safest approach is to contact the transplant team promptly when new or unusual symptoms appear.

Causes and Risk Factors

Rejection occurs because the immune system detects differences between the recipient’s body and the donor organ. Before transplant, teams reduce this risk through blood type matching, tissue typing, antibody screening, and crossmatch testing. Even with excellent matching, some immune response is possible because no donated organ is a perfect genetic match except in rare identical twin situations.

One of the most important preventable risk factors is missed or irregular immunosuppressive medication. Skipping doses, taking medicines at the wrong time, stopping treatment because of side effects, or taking interacting drugs can increase the chance of rejection. Patients should tell their transplant team about all prescription medicines, over-the-counter products, herbal supplements, and major diet changes.

Other risk factors can include previous transplant, previous blood transfusions or pregnancies that created antibodies, infections that activate the immune system, and certain differences between donor and recipient tissue markers. Chronic conditions such as high blood pressure, diabetes, high cholesterol, or smoking may also contribute to long-term organ damage and make chronic rejection harder to manage.

Rejection risk is highest during some periods, such as the early months after transplant or after medication changes, but it never fully disappears. Long-term success depends on a partnership between the patient, caregivers, and the transplant team.

Diagnosis and Monitoring

Diagnosing organ transplant rejection usually begins with a review of symptoms, medication use, physical examination, and routine blood or urine tests. For example, kidney function may be checked with creatinine and urine tests, liver function with liver enzymes and bilirubin, and heart or lung function with specialized tests. Trends over time are often more important than a single result.

Imaging may be used to look for complications that can mimic rejection, such as blocked blood vessels, bile duct problems, fluid collections, urinary obstruction, or infection. Ultrasound, CT, MRI, echocardiography, or lung function testing may be selected depending on the transplanted organ and the patient’s symptoms.

A biopsy is often the most direct way to confirm rejection and identify its type. During a biopsy, a small tissue sample from the transplanted organ is examined under a microscope. The results help doctors distinguish cellular rejection, antibody-mediated rejection, infection, medication toxicity, or other causes of organ dysfunction.

Monitoring also includes measuring levels of certain immunosuppressive medicines in the blood. These levels help the team balance protection against rejection with the risk of side effects, infections, or toxicity. Patients should attend scheduled tests even when they feel well.

Treatment Options

Treatment depends on the transplanted organ, the severity of rejection, the time since transplant, biopsy findings, antibody results, and the patient’s overall health. Mild rejection may be managed by adjusting maintenance immunosuppressive medicines. More significant rejection may require short courses of stronger anti-inflammatory or immune-targeting treatments given in hospital or under close supervision.

For cellular rejection, doctors may use corticosteroids or other medicines that reduce immune cell activity. For antibody-mediated rejection, treatment may include therapies that lower harmful antibodies or reduce antibody-producing immune responses. The exact plan is individualized, and patients should not compare their treatment directly with another transplant patient’s regimen.

Supportive care is also important. This may include treating infection, controlling blood pressure, managing blood sugar and cholesterol, optimizing hydration, and reviewing medicines that could harm the transplanted organ. If rejection has caused significant organ dysfunction, care may involve a wider team, including transplant surgeons, nephrologists, hepatologists, cardiologists, pulmonologists, pharmacists, dietitians, and nurses.

In some cases, chronic rejection progresses despite treatment. When organ function becomes severely reduced, the team may discuss advanced supportive therapies, dialysis for kidney failure, or evaluation for re-transplantation when appropriate. These decisions are made carefully and individually.

Prevention and Self-Care

Patients cannot prevent every rejection episode, but they can lower risk by following the transplant plan closely. The most important step is taking immunosuppressive medicines exactly as prescribed. If side effects, cost concerns, travel schedules, vomiting, or missed doses occur, the patient should contact the transplant team for instructions rather than making changes alone.

Practical self-care includes keeping all follow-up appointments, completing laboratory tests on schedule, monitoring blood pressure or blood sugar when advised, and reporting symptoms early. Patients may be asked to track weight, temperature, urine output, oxygen levels, or lung function depending on the organ transplanted.

Because immunosuppressive medicines increase infection risk, prevention is part of transplant care. Patients should follow vaccination guidance from their transplant team, practice good hand hygiene, avoid close contact with people who have contagious illnesses when possible, and follow food safety advice. Live vaccines and certain supplements may not be safe for some transplant recipients, so professional guidance is essential.

Healthy lifestyle habits also support long-term organ function. These include not smoking, limiting alcohol according to medical advice, staying physically active as recommended, eating a balanced diet, maintaining a healthy weight, and protecting skin from excessive sun exposure because some immunosuppressive medicines increase skin cancer risk.

When to See a Doctor

Transplant recipients should contact their transplant team promptly for fever, new pain or tenderness near the transplant site, reduced urine output, shortness of breath, jaundice, swelling, sudden weight gain, chest discomfort, persistent vomiting or diarrhea, or any significant change in how they feel. It is also important to call if doses of immunosuppressive medicine are missed or cannot be kept down.

Urgent medical attention is needed for severe shortness of breath, fainting, chest pain, confusion, signs of severe infection, or rapidly worsening symptoms. Because infection and rejection can look similar, early assessment helps the medical team choose safe treatment quickly.

Patients traveling internationally after transplant should carry a current medication list, transplant center contact information, and recent medical summaries if available. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat transplant-related complications, including rejection, for international patients in coordination with their ongoing care needs.

Frequently asked questions

Does transplant rejection mean the organ has failed?

Not always. Many rejection episodes, especially acute rejection, can be treated when detected early. The outcome depends on the type and severity of rejection, how quickly it is diagnosed, and how the organ responds to treatment.

Can rejection happen years after a transplant?

Yes. The risk is usually higher in the early period after transplant, but rejection can occur at any time. Chronic rejection may develop gradually over years, which is why lifelong follow-up is important.

Can a patient feel normal during rejection?

Yes. Some rejection episodes cause no symptoms at first and are found through routine blood tests, imaging, lung function tests, or biopsy. Patients should keep scheduled monitoring appointments even when they feel well.

What should a patient do after missing an anti-rejection medicine dose?

The patient should contact the transplant team or follow the written instructions provided by that team. They should not double doses or stop other medicines unless specifically advised, because safe instructions depend on the medication and timing.

Are infections and rejection related?

They are different problems, but they can be connected. Immunosuppressive medicines reduce rejection risk but can increase infection risk, while some infections can stimulate the immune system. Symptoms may overlap, so medical evaluation is important.

Can lifestyle choices help protect a transplanted organ?

Yes. Taking medicines correctly, attending follow-up visits, not smoking, following infection-prevention advice, and managing blood pressure, diabetes, cholesterol, and weight can all support long-term transplant health. These steps do not replace medical treatment but are an important part of care.

References

• American Society of Transplantation
• United Network for Organ Sharing
• National Institute of Diabetes and Digestive and Kidney Diseases
• European Society for Organ Transplantation
• NHS Blood and Transplant

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.